Anne Wojcicki's nonprofit is set to purchase all significant assets of the bankrupt genetic testing company, 23andMe, for ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.

A nonprofit led by Anne Wojcicki, the co-founder and former chief executive of 23andMe, won a bid to acquire the genetic ...

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN), an American biotechnology company, on Monday announced that it planned to acquire 23andMe Holding Co.'s Personal Genome Service, Total Health ...

Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.

SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered ...

Deal includes 23andMe’s Biobank, Personal Genome Service, Total Health, and research services operations. Regeneron Pharmaceuticals has announced an agreement to acquire all assets of 23andMe for $256 ...

This includes the company’s Personal Genome Service (PGS) and Total Health and Research Services business lines, but not the Lemonaid Health subsidiary. Lemonaid Health, a telehealth company ...

The acquisition, valued at $256 million, includes 23andMe’s Personal Genome Service, Total Health and Research Services, Biobank, and associated assets. Regeneron intends for 23andMe to continue ...

REGN intends to acquire its Personal Genome Service, Total Health, and Research Services business line, together with its Biobank and associated assets, but does not include its Lemonaid Health ...

Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS), Total Health and Research Services business lines, together with its Biobank and associated assets, for $256 million and for ...

The transaction, expected to close in the third quarter of 2025, includes 23andMe’s core Personal Genome Service, Total Health and Research Services, and a vast biobank of customer genetic data ...